|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/436 | |
| A61K 31/4745 | |||
| A61K 31/5377 | |||
| A61K 31/52 | |||
| A61K 31/496 | |||
| A61K 45/06 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2675450 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12705457.5 |
| Europos patento paraiškos padavimo data | 2012-02-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-12-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2012/050669 |
| Data | 2012-02-14 |
| (87) | Numeris | WO 2012/110953 |
| Data | 2012-08-23 |
| (30) | Numeris | Data | Šalis |
| 201161443493 P | 2011-02-16 | US |
| (72) |
GALIMBERTI, Ivan, CH
MURPHY, Leon, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATIONS OF THERAPEUTIC AGENTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |
| COMBINATIONS OF THERAPEUTIC AGENTS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES |